Mutation profile and programmed death ligand 1 status of patients with non‐small cell lung cancer diagnosed with “adenocarcinoma” and “non‐small cell carcinoma favor adenocarcinoma”

Mutation profile and programmed death ligand 1 status of patients with non‐small cell lung cancer diagnosed with “adenocarcinoma” and “non‐small cell carcinoma favor adenocarcinoma”

Abstract Background The terminology for lung cancer diagnosis in small biopsies was adopted in the 2015 World Health Organization classification. If non‐small cell lung cancer (NSCLC) has no clear adenocarcinoma (AD) or squamous cell carcinoma morphology, the tumor is further classified based on muc...

Full description

Bibliographic Details
Main Authors: Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, Tetsuya Isaka, Kanako Shinada, Emi Yoshioka, Atsuya Narita, Kengo Katakura, Tetsuro Kondo, Terufumi Kato, Takuya Nagashima, Haruhiro Saito, Hiroyuki Ito
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Thoracic Cancer
Subjects:
biopsy
epidermal growth factor receptor (EGFR)
next‐generation sequencing panel
non‐small cell lung cancer
programmed death ligand 1 (PD‐L1)
Online Access:https://doi.org/10.1111/1759-7714.15214

Internet

https://doi.org/10.1111/1759-7714.15214

Similar Items